Level B Criteria (*): Requires at least one of ABX, or FMT, to be Yes
This unique design allows for the medication to be absorbed through the oral mucosa, leading to targeted local or systemic effects
then the Privacy Policy above includes language that is meant to account for such compliance
10.1111/j.1365-2605.2007.00849.x 149
Also known as: Akos024437838 Molecular Formula C 11 H 21 NO 9 Molecular Weight 311.29 g/mol InChI Key RZALONVQKUWRRY-XOJLQXRJSA-N 1 2D Structure 2 Identification 2.1 Computed Descriptors 2.1.1 IUPAC Name (2R,3R)-2,3-dihydroxybutanedioic acid;(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate 2.1.2 InChI InChI=1S/C7H15NO3.C4H6O6/c1-8(2,3)5-6(9)4-7(10)11;5-1(3(7)8)2(6)4(9)10/h6,9H,4-5H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-;1-,2-/m11/s1 2.1.3 InChI Key RZALONVQKUWRRY-XOJLQXRJSA-N 2.1.4 Canonical SMILES C[N+](C)(C)CC(CC(=O)[O-])O.C(C(C(=O)O)O)(C(=O)O)O 2.1.5 Isomeric SMILES C[N+](C)(C)C[C@@H](CC(=O)[O-])O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O 2.2 Synonyms 2.2.1 Depositor-Supplied Synonyms 2.3 Create Date 3 Chemical and Physical Properties
